atevirdine has been researched along with Dermatitis Medicamentosa in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batts, DH; Demeter, LM; Fischl, MA; Greisberger, C; Holden-Wiltse, J; Leedom, J; Meehan, PM; Morse, G; Nevin, T; Para, M; Powderly, W; Reichman, RC; Resnick, L; Timpone, J; Wathen, LK; Wood, K | 1 |
1 trial(s) available for atevirdine and Dermatitis Medicamentosa
Article | Year |
---|---|
Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patients.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cells, Cultured; Cohort Studies; Drug Eruptions; Drug Resistance, Microbial; Female; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Piperazines; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load | 1998 |